elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24202071-083E959A-AA33-422D-AFA0-C0530319F3C5
Q24202071-083E959A-AA33-422D-AFA0-C0530319F3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24202071-083E959A-AA33-422D-AFA0-C0530319F3C5
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
P2860
Q24202071-083E959A-AA33-422D-AFA0-C0530319F3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24202071-083E959A-AA33-422D-AFA0-C0530319F3C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
738623f111e690eb3785e3237e9659eb1da3700d
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer